Skip to main content
Monthly Archives

September 2022

Drug Target Review: Synthetic biology is ready for the therapeutic limelight

By Featured News, News

After initially serving as a proving ground for integrating forward engineering principles into living cells, synthetic biology is making waves across diverse therapeutic areas. In this article, Dr. Dan Mandell, Co-Founder and CEO of GRO Biosciences, explains how the field is reshaping our understanding of the limits of cell- and molecular-based medicines.

Read More